• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

替代指标，朋友还是敌人？在成本效益分析中使用替代结局的案例研究需求。

Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses.

出版信息

Health Econ. 2013 Feb;22(2):251-2. doi: 10.1002/hec.2826. Epub 2012 May 24.

DOI:10.1002/hec.2826
PMID:22623328
Abstract

We comment on a recent article by Hawkins et al. presenting different analytic approaches for the inclusion of surrogate and final outcomes in cost-effectiveness analyses. This methodological case study provides a timely and valuable contribution to build on the debate about the use of evidence based on surrogate outcomes in health technology assessment.

摘要

我们对 Hawkins 等人最近发表的一篇文章进行了评论，该文章提出了在成本效益分析中纳入替代和最终结局的不同分析方法。这项方法学案例研究为基于替代结局的证据在卫生技术评估中的使用这一争论提供了及时且有价值的贡献。

相似文献

1
Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses.替代指标，朋友还是敌人？在成本效益分析中使用替代结局的案例研究需求。
Health Econ. 2013 Feb;22(2):251-2. doi: 10.1002/hec.2826. Epub 2012 May 24.
2
Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach.替代指标、荟萃分析和成本效益建模：一种联合分析方法。
Health Econ. 2012 Jun;21(6):742-56. doi: 10.1002/hec.1741. Epub 2011 Jul 28.
3
A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.用于精神健康临床试验中替代终点评估的统一框架。
Stat Methods Med Res. 2010 Jun;19(3):205-36. doi: 10.1177/0962280209105015. Epub 2009 Jul 16.
4
Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints.探索因果推断与荟萃分析范式在替代终点评估中的关系。
Stat Med. 2016 Apr 15;35(8):1281-98. doi: 10.1002/sim.6807. Epub 2015 Nov 26.
5
Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints.普伦蒂斯的方法与元分析范式：对统计学在替代终点评估中作用的反思
Biometrics. 2004 Sep;60(3):724-8. doi: 10.1111/j.0006-341X.2004.00222.x.
6
The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports.基于模型的成本效益分析中替代结局的使用：对英国卫生技术评估报告的一项调查
Health Technol Assess. 2009 Jan;13(8):iii, ix-xi, 1-50. doi: 10.3310/hta13080.
7
Quantifying the effect of the surrogate marker by information gain.通过信息增益量化替代标志物的效应。
Biometrics. 2007 Sep;63(3):958-62; author reply 962-3. doi: 10.1111/j.1541-0420.2007.00852_1.x.
8
Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints.替代终点验证过程中的决策是否会随治疗效果的显著性水平而改变？关于替代终点验证的一项提议。
Contemp Clin Trials. 2009 Jan;30(1):8-12. doi: 10.1016/j.cct.2008.08.006. Epub 2008 Sep 9.
9
[Meta-analyses or megatrials: same level of proof?].
Presse Med. 2007 Mar;36(3 Pt 2):524-30. doi: 10.1016/j.lpm.2007.01.019. Epub 2007 Feb 1.
10
On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints.关于因果推断与荟萃分析范式在替代终点验证中的关系。
Biometrics. 2015 Mar;71(1):15-24. doi: 10.1111/biom.12245. Epub 2014 Oct 1.

引用本文的文献

1
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study.经济评估和委托重点关注相同的结果吗？以英格兰为例的资源配置考虑因素和挑战。
Appl Health Econ Health Policy. 2024 Jul;22(4):435-445. doi: 10.1007/s40258-024-00875-3. Epub 2024 Mar 11.
2
Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.实现欧盟成员国平等、及时地获得创新抗癌药物的机会：以中东欧和东南欧国家为重点的跨学科 CECOG 驱动圆桌讨论综述。
ESMO Open. 2019 Nov 13;4(6):e000550. doi: 10.1136/esmoopen-2019-000550. eCollection 2019.
3
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.比较随机对照试验中替代和最终与患者相关结局的治疗效果大小：Meta 流行病学研究。
BMJ. 2013 Jan 29;346:f457. doi: 10.1136/bmj.f457.